Screener
Inhibrx Biosciences, Inc. INBX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Interest expense | (3,509) | (2,689) |
| Interest income | 1,007 | 2,329 |
| Other income (expense), net | (12) | (50) |
| Total other expense | (2,514) | (410) |
| Loss before income tax expense | (33,441) | (43,311) |
| Provision for income taxes | — | — |
| Net loss | $(33,441) | $(43,311) |
| Net loss per share, basic and diluted | $(2.15) | $(2.80) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s other income (expense)?
- Inhibrx Biosciences, Inc. (INBX) reported other income (expense) of -$2.51M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s other income (expense) changed year-over-year?
- Inhibrx Biosciences, Inc.'s other income (expense) decreased by 513.2% year-over-year, from -$410K to -$2.51M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s other income (expense)?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s other income (expense) has grown at a -50.5% compound annual growth rate (CAGR), from -$20.5M to -$5.03M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Inhibrx Biosciences, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude